BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 11268968)

  • 21. Liver expression of proteins controlling interferon-mediated signalling as predictive factors in the response to therapy in patients with hepatitis C virus infection.
    Bautista D; Bermúdez-Silva FJ; Lasarte JJ; Rodriguez-Fonseca F; Baixeras E
    J Pathol; 2007 Nov; 213(3):347-55. PubMed ID: 17940994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Early hepatic stellate cell activation is associated with advanced fibrosis after liver transplantation in recipients with hepatitis C.
    Russo MW; Firpi RJ; Nelson DR; Schoonhoven R; Shrestha R; Fried MW
    Liver Transpl; 2005 Oct; 11(10):1235-41. PubMed ID: 16184580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decorin and actin expression and distribution in patients with chronic hepatitis C following interferon-alfa-2b treatment.
    Jármay K; Gallai M; Karácsony G; Ozsvár Z; Schaff Z; Lonovics J; Kovalszky I
    J Hepatol; 2000 Jun; 32(6):993-1002. PubMed ID: 10898320
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon.
    Tappero G; Farina M; Negro F; Anfossi G; Mattiello L; Giuli PD; Colombatto P; Brunetto MR; Angeli A; Bonino F
    Ital J Gastroenterol Hepatol; 1997 Apr; 29(2):148-54. PubMed ID: 9646196
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic expression of c-Myb in chronic human liver disease.
    Kitada T; Seki S; Nakatani K; Kawada N; Kuroki T; Monna T
    Hepatology; 1997 Dec; 26(6):1506-12. PubMed ID: 9397991
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinicopathologic observations on chronic hepatitis C therapy with interferon-alpha].
    Jármay K; Lonovics J; Schaff Z
    Orv Hetil; 2003 Jul; 144(27):1325-30. PubMed ID: 12908145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relationship between plasma cells and hepatic stellate cells in autoimmune hepatitis.
    Brandão DF; Ramalho FS; Martinelli AL; Zucoloto S; Ramalho LN
    Pathol Res Pract; 2010 Dec; 206(12):800-4. PubMed ID: 20926203
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of transferrin receptor 2 in hepatic accumulation of iron in patients with chronic hepatitis C.
    Mifuji R; Kobayashi Y; Ma N; Qiang QL; Urawa N; Horiike S; Iwasa M; Kaito M; Malavasi F; Adachi Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):144-51. PubMed ID: 16706826
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rat hepatic lipocytes express smooth muscle actin upon activation in vivo and in culture.
    Rockey DC; Boyles JK; Gabbiani G; Friedman SL
    J Submicrosc Cytol Pathol; 1992 Apr; 24(2):193-203. PubMed ID: 1600511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatic iron overload does not prevent a sustained virological response to interferon-alpha therapy: a long term follow-up study in hepatitis C-infected patients with beta thalassemia major.
    Sievert W; Pianko S; Warner S; Bowden S; Simpson I; Bowden D; Locarnini S
    Am J Gastroenterol; 2002 Apr; 97(4):982-7. PubMed ID: 12003436
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B.
    Di Martino V; Thevenot T; Colin JF; Boyer N; Martinot M; Degos F; Coulaud JP; Vilde JL; Vachon F; Degott C; Valla D; Marcellin P
    Gastroenterology; 2002 Dec; 123(6):1812-22. PubMed ID: 12454838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatic stellate cell activation and hepatic fibrosis in children with type 1 autoimmune hepatitis: an immunohistochemical study of paired liver biopsies before treatment and after clinical remission.
    Maia JM; Maranhão Hde S; Sena LV; Rocha LR; Medeiros IA; Ramos AM
    Eur J Gastroenterol Hepatol; 2010 Mar; 22(3):264-9. PubMed ID: 20009940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Early hepatic stellate cell activation predicts severe hepatitis C recurrence after liver transplantation.
    Gawrieh S; Papouchado BG; Burgart LJ; Kobayashi S; Charlton MR; Gores GJ
    Liver Transpl; 2005 Oct; 11(10):1207-13. PubMed ID: 16184568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Efficacy of combination therapy with interferon-alpha and ribavirin for chronic hepatitis C in relation to liver fibrosis and serum aminotransferase activity].
    Karpińska E; Wawrzynowicz-Syczewska M; Jurczyk K; Morańska I; Urbanowicz W; Boroń-Kaczmarska A
    Wiad Lek; 2005; 58(11-12):616-21. PubMed ID: 16594470
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term monitoring of platelet count, as a non-invasive marker of hepatic fibrosis progression and/or regression in patients with chronic hepatitis C after interferon therapy.
    Taniguchi H; Iwasaki Y; Fujiwara A; Sakaguchi K; Moriya A; Yu PC; Takaki A; Fujioka S; Shimomura H; Shiratori Y
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):281-7. PubMed ID: 16460487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological response to interferon alfa-based therapies in hepatitis C.
    Lee SS
    Semin Liver Dis; 2004; 24 Suppl 2():55-60. PubMed ID: 15346247
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatic stellate cells in human schistosomiasis mansoni: a comparative immunohistochemical study with liver cirrhosis.
    Chang D; Ramalho LN; Ramalho FS; Martinelli AL; Zucoloto S
    Acta Trop; 2006 Mar; 97(3):318-23. PubMed ID: 16473318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis C virus-associated hypobetalipoproteinemia is correlated with plasma viral load, steatosis, and liver fibrosis.
    Petit JM; Benichou M; Duvillard L; Jooste V; Bour JB; Minello A; Verges B; Brun JM; Gambert P; Hillon P
    Am J Gastroenterol; 2003 May; 98(5):1150-4. PubMed ID: 12809841
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular bases of hepatic fibrogenesis - genetic and therapeutical implications in chronic viral C hepatitis.
    Rogoveanu I; Săndulescu DL; Gheonea DI; Ciurea T; Comănescu V
    Rom J Morphol Embryol; 2008; 49(1):21-5. PubMed ID: 18273498
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A morphometric and immunohistochemical study to assess the benefit of a sustained virological response in hepatitis C virus patients with cirrhosis.
    D'Ambrosio R; Aghemo A; Rumi MG; Ronchi G; Donato MF; Paradis V; Colombo M; Bedossa P
    Hepatology; 2012 Aug; 56(2):532-43. PubMed ID: 22271347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.